Medical Testing ANTIGEN DETECTION ASPERGILLUS EIA GALACTOMANNAN TEST BETA-D GLUCAN ASSAY BLASTOMYCES QUANTITATIVE EIA TEST COCCIDIOIDES QUANTITATIVE EIA TEST CRYPTOCOCCUS LATEX AGGLUTINATION TEST HISTOPLASMA QUANTITATIVE EIA TEST ANTIBODY DETECTION ASPERGILLUS ANTIBODY IMMUNODIFFUSION BLASTOMYCES ANTIBODY IMMUNODIFFUSION COCCIDIOIDES ANTIBODY IGG IGM EIA COCCIDIOIDES ANTIBODY IMMUNODIFFUSION HISTOPLASMA ANTIBODY IGG IGM EIA HISTOPLASMA ANTIBODY IMMUNODIFFUSION Veterinary Testing IVD Devices
MiraVista Diagnostics是业界领先的真菌学参考实验室
MiraVista Diagnostics是一家经CLIA和CAP认证的真菌学参考实验室(RL),专门致力于开发和处理严重真菌感染的诊断测试。我们为皮炎芽生菌、荚膜组织胞浆菌、隐球菌、球虫病、曲霉和β-D葡聚糖的检测、监测和诊断测试提供最高的临床准确性和敏感性标准。
严重真菌感染的临床实验室检测
该公司由著名的传染病科学家劳伦斯·约瑟夫·麦特博士于2002年创立,他的开创性研究贡献导致了1986年第一次组织胞浆菌病抗原检测的发展。如今,MiraVista Diagnostics服务于美国和加拿大的医疗和保健部门,每年处理超过100000次真菌感染检测。这包括球虫(谷热真菌)、曲霉菌、荚膜组织胞浆菌病、皮炎芽生菌和隐球菌的抗原和抗体检测。
MiraVista Diagnostics is an Industry Leading Mycology Reference Laboratory MiraVista Diagnostics is a CLIA and CAP certified mycology reference laboratory (RL) with an exclusive focus on developing and processing diagnostic tests for serious fungal infections. We offer the highest standards in clinical accuracy and sensitivity for detection, monitoring and diagnostic testing for blastomyces dermatitidis, histoplasma capsulatum, cryptococcus, coccidioides, aspergillus and beta-D glucan. Clinical Laboratory Testing for Serious Fungal Infections The company was founded in 2002 by the renowned infectious disease scientist, Dr. Lawrence Joseph Wheat, whose groundbreaking research contributions resulted in the development of the first histoplasmosis antigen test in 1986. Today, MiraVista Diagnostics serves the medical and healthcare sectors in the U.S. and Canada processing over 100,000 tests per year for fungal infections. This includes antigen and antibody detection tests for coccidioides (valley fever fungus), aspergillus, histoplasmosis capsulatum, Blastomyces dermatitidis and cryptococcus.